Get informed when a big investor buys or sells
+ FollowOvervalued by 54.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $252.08 Million |
|---|---|
| Enterprise Value | $247.23 Million |
| Annual dividend | $0.60 |
| Dividend yield | 7.13% |
| Earnings per Share | $0.88 |
| Beta | 0.53 |
| Outstanding Shares | 29,937,836 |
| P/E Ratio | 6.74 |
|---|---|
| PEG | 6.26 |
| Price to Sales | 0.86 |
| Price to Book Ratio | 2.15 |
| Enterprise Value to Revenue | 0.77 |
| Enterprise Value to EBIT | 5 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.28 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Established in 2005 in Warsaw, Poland, IPOPEMA Securities S.A. is a financial services firm delivering a comprehensive range of brokerage, equity research, and investment banking solutions. The company's operations are organized into dis...